Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Insomnia Drug Development Programs Must Include Driving Studies, FDA Says

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

Agency will require driving simulation studies for all new sleep aids and is asking sponsors of currently approved products to conduct such trials. FDA is directing zolpidem-containing product manufacturers to make labeling changes based, in part, on driving data submitted for Transcept’s Intermezzo.

You may also be interested in...

Drug Effects On Driving Need Tiered Evaluation, FDA Says; Patient Reports Inadequate

Draft guidance describes various analyses and studies that can determine a drug’s effect on driving but doesn’t offer much advice on how to determine when a drug needs to progress to a higher level of scrutiny.

Transcept Gains Long-Delayed Approval Of Intermezzo

Indication for insomnia characterized by middle-of-the-night awakening followed by difficulty returning to sleep is a first.

Transcept's NDA Intermission For Insomnia Drug Intermezzo Set To End In First Quarter

Results from a driving impairment study strengthen the case for approval, the company says.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts